rulicity, a long-acting GLP-1 analogue developed by Eli Lilly for a single subcutaneous injection per week, was approved in the United States in September 2014 for the treatment of type 2 diabetes. St…
Lixiela is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone that helps normalize blood sugar levels. The safety and efficacy of this drug were evaluated in 10 clinical trials, wh…
Retalutide (LY3437943) is a glucose-dependent insulin-like polypeptide, an agonist of glucagon-like peptide 1 and glucagon receptors. The dose-response relationship in terms of side effects, safety an…
Liraglutide is a transparent and colorless solution. The dosage form is subcutaneous injection. Liraglutide, after more than 10 years of research and development, has numerous functions such as promot…
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea